Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Noble Romans (NROM) Cash & Equivalents (2016 - 2025)

Noble Romans has reported Cash & Equivalents over the past 15 years, most recently at $719500.0 for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 30.47% year-over-year to $719500.0; the TTM value through Sep 2025 reached $719500.0, up 30.47%, while the annual FY2024 figure was $710227.0, 18.58% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $719500.0 at Noble Romans, up from $635629.0 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $2.0 million in Q2 2021 and troughed at $463283.0 in Q1 2023.
  • A 5-year average of $942727.5 and a median of $785522.0 in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: plummeted 58.48% in 2022 and later surged 151.48% in 2024.
  • Year by year, Cash & Equivalents stood at $1.3 million in 2021, then crashed by 37.83% to $785522.0 in 2022, then grew by 11.05% to $872335.0 in 2023, then decreased by 18.58% to $710227.0 in 2024, then rose by 1.31% to $719500.0 in 2025.
  • Business Quant data shows Cash & Equivalents for NROM at $719500.0 in Q3 2025, $635629.0 in Q2 2025, and $564637.0 in Q1 2025.